Showing 761 - 780 results of 39,340 for search '(( 5 ((non decrease) OR (point decrease)) ) OR ( 100 ((nm decrease) OR (a decrease)) ))', query time: 1.23s Refine Results
  1. 761
  2. 762
  3. 763
  4. 764
  5. 765
  6. 766
  7. 767
  8. 768
  9. 769
  10. 770
  11. 771
  12. 772

    Vaccination Against Lawsonia intracellularis Decreases Shedding of Salmonella enterica serovar Typhimurium in Co-Infected Pigs and Alters the Gut Microbiome by Fernando L.L. Leite (17479485)

    Published 2024
    “…Typhimurium</em> and <em>L. intracellularis</em> and vaccinated against <em>L. intracellularis</em> (Sal Law Vac), and 5) non-infected control (Control).</p> <p>Deposited here are fastq files of sequencing of the V1-V3 region of the 16S rRNA gene from feces of each animal of the study from the time point of prior to infection (0 days post infection) to 49 days post infection. …”
  13. 773
  14. 774
  15. 775

    Analysis of the <sup>1</sup>H-<sup>15</sup>N HSQC Spectra of mS100A4 in Complex with EGF. by Ching Chang Cho (3080076)

    Published 2016
    “…<p>(A) Overlaid <sup>1</sup>H-<sup>15</sup>N HSQC spectra of 0.5 mM <sup>15</sup>N-labeled free mS100A4 (red) and mS100A4: EGF, molar ratio = 1:0.3 (green), 1:0.6 (blue), and 1:1 (white), with the intensity drop indicated by green boxes. …”
  16. 776

    Analysis of the <sup>1</sup>H-<sup>15</sup>N HSQC Spectra of mS100A4 in Complex with Amlexanox. by Ching Chang Cho (3080076)

    Published 2016
    “…(C) Ribbon representation of mS100A4, with residues that exhibited a decrease in cross-peak intensity mapped (red) on the ribbon diagram.…”
  17. 777

    Sarcopenia as an Independent Risk Factor for Decreased BMD in COPD Patients: Korean National Health and Nutrition Examination Surveys IV and V (2008-2011) by Dong-Won Lee (2208223)

    Published 2016
    “…</p><p>Methods</p><p>COPD patients aged 50 or older with qualifying spirometry and dual-energy X-ray absorptiometry data were from participants in the Korean National Health and Nutrition Examination Surveys IV and V (2008–2011).</p><p>Results</p><p>There were 286 (33.3%) subjects in the sarcopenia group and 572 (66.7%) in the non-sarcopenia group. …”
  18. 778
  19. 779
  20. 780